Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.54%
1,100.44
-5.92
-0.54%
—1,106.361,105.681,109.291,096.52——
SIXC
Communications
SIXC
Communications
SIXC
+0.71%
614.63
+4.34
+0.71%
—610.29610.29616.60610.29——
SIXE
Energy
SIXE
Energy
SIXE
+0.50%
1,217.33
+6.11
+0.50%
—1,211.221,211.011,220.571,208.50——
SIXI
Industrials
SIXI
Industrials
SIXI
+0.27%
1,755.47
+4.76
+0.27%
—1,750.711,753.101,762.131,743.30——
SIXM
Financials
SIXM
Financials
SIXM
+0.75%
632.88
+4.71
+0.75%
—628.17629.38634.09629.38——
SIXR
Staples
SIXR
Staples
SIXR
+0.46%
858.46
+3.89
+0.46%
—854.57855.71859.66855.45——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.22%
216.40
-0.47
-0.22%
—216.87216.87217.79216.17——
SIXT
Technology
SIXT
Technology
SIXT
+1.54%
3,616.65
+54.71
+1.54%
—3,561.943,571.443,628.583,562.15——
SIXU
Utilities
SIXU
Utilities
SIXU
+0.09%
904.09
+0.87
+0.09%
—903.31903.26906.56901.18——
SIXV
Health care
SIXV
Health care
SIXV
+0.03%
1,482.05
+0.51
+0.03%
—1,481.541,482.481,488.461,474.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.51%
2,412.23
+12.28
+0.51%
—2,399.952,404.452,418.812,398.09——
ESPR:NASDAQ
Esperion Therapeutics Inc
$3.12
+0.16%
(+0.0050) 1D
May 14, 12:39:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ESPR...
Open
$3.12
High
$3.13
Low
$3.11
Mkt. cap
804.47M
Avg. vol.
16.62M
Volume
13.30M
52-wk high
$4.18
52-wk low
$0.69
EPS
-$0.06
Beta
0.91
Shares outstanding
257.43M
No. of employees
294
News stories
From sources across the web
Profile
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan. Wikipedia
About Esperion Therapeutics Inc
CEOSheldon Koenig
Employees294
FoundedMay 1998
Headquarters-
SectorPharmaceutical industry
Websiteesperion.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
82.38M
87.31M
168.45M
80.10M
Cost of goods sold
35.78M
55.42M
41.78M
43.56M
Cost of revenue
35.78M
55.42M
41.78M
43.56M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
39.51M
41.85M
41.43M
43.12M
Operating expense
39.51M
41.85M
41.43M
43.12M
Total operating expenses
75.29M
97.27M
83.21M
86.68M
Operating income
7.10M
-9.96M
85.23M
-6.58M
Other non operating income
66.00K
-23.00K
-25.00K
-17.00K
EBT including unusual items
-12.72M
-31.33M
63.67M
-25.20M
EBT excluding unusual items
-12.72M
-31.33M
63.67M
-25.20M
Income tax expense
-
-
1.84M
-
Effective tax rate
-
-
2.89%
-
Other operating expenses
-
-
-
-
Net income
-12.72M
-31.33M
61.83M
-25.20M
Net profit margin
-15.45%
-35.89%
36.71%
-31.45%
Earnings per share
-0.02
-0.16
0.22
-0.10
Interest and investment income
600.00K
700.00K
1.10M
1.20M
Interest expense
-20.49M
-22.05M
-22.64M
-19.80M
Net interest expenses
-19.89M
-21.35M
-21.54M
-18.60M
Depreciation and amortization charges
-
-
-
-
EBITDA
7.12M
-9.93M
85.26M
-6.55M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer